fbpx Skip to main navigation Skip to content

U.S. Inflation: As our economy rebounds from the Covid-19 crisis, U.S. inflation rates increased to the highest levels since 2008. Up from 1.4% in January, inflation in the past 12 months is at 5%, with fears rising over increasing prices in the U.S. The good news is stocks have rallied with the realization that the economic stimulus is here to stay and that the magnitude of these price increases may likely be transitory.

Good News for our treatment of 529s: We are delighted to share some news that some of you already know. Our firm no longer charges management fees for 529s! So, if you or anyone you know is considering saving for a loved one’s education with this particular vehicle, now would be a great time to start a conversation with one of our advisors. What’s a 529 College Savings Plan, you may ask? Click here to learn more.


Elon Musk and Bitcoin: Elon Musk has sent bitcoin prices on a rollercoaster ride this year. When he added #bitcoin to his Twitter bio in January, prices jumped 20%. While Tesla, Inc. purchased $1.5 billion worth of cryptocurrency, they also revealed they would no longer accept bitcoin for payment for vehicles. Investors aren’t thrilled about Musk’s influence on the bitcoin market through social media. But the volatility in the market the past month has reminded investors why they’re wary of cryptocurrency.

Alzheimer’s Drug Approval and FDA Advisory Panel Resignations: The FDA has decided to move ahead with approving Biogen Inc’s Alzheimer’s disease treatment despite three advisers resigning. Members of a panel who advise the U.S. Food and Drug Administration are protesting the approval through their resignations. The 11-member committee was nearly unanimous in their November vote that the drug should not be approved. The FDA, however, gave the drug “accelerated approval,” citing evidence that it can reduce a likely contributor to the disease.